Labcorp and Covance launch extensive preclinical, clinical and post-approval cell and gene therapy development solutions

Specialized Expertise, Coordinated Capabilities and Targeted Investments Designed to Accelerate Development and Reduce Risk for Sponsors BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- Labcorp® (NYSE:LH), a leading global life sciences company that is deeply integrated in guiding patient care,

LabCorp is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2020-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14 at 1:30 p.m. (PT) .

Concentration of branched-chain amino acids is a strong risk marker for incident hypertension

LabCorp and Covance Connect Sponsors with Patients Virtually with an Expanded Suite of Decentralized Trial Solutions

BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 18, 2019-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today unveiled its latest solution for decentralized clinical trials from Covance to help transform the conduct of hybrid and virtual